Lithium Pilocarpine Status Epilepticus
Discover how Melior’s unique phenotypic screening platforms can uncover the untapped value of your candidate therapeutic
Status epilepticus (SE) is a form of epileptic seizure that is resistant to treatment with standard anti-epileptic drugs, in particular, benzodiazepines, when they are administered more than 1 h post-onset. Abrogation of the seizures, in that case, is very difficult, requiring days or weeks of treatment, and may ultimately fail.
SE is most often investigated using the lithium-pilocarpine rat model in which pilocarpine is used to initiate the seizures. At Melior we can quantitatively evaluate treatment effects using EEG recording across a wide frequency range (0.3-96 Hz).
We can assess the anti-convulsant activity of diazepam administered intravenously (IV) in a model of status epilepticus (SE) induced by pilocarpine (Morrisett et al., 1987). Diazepam was administered 0, 15, or 60 minutes after onset of SE and compared to vehicle administered at 0 or 60 minutes post SE onset.
Cortical EEG activity was recorded in rats before and after administration of pilocarpine to induce SE. Animals were pre-treated with LiCl to enhance and improve the reliability of seizure induction. EEG activity was recorded for 5 h after SE onset, and anticonvulsant activity was assessed by determining changes in EEG power over frequency ranges from 1 to 96 Hz.
The figure below shows a typical example of an animal before and after initiating SE. The EEG activity is increased across all frequencies by over 10 fold. Treatment with vehicle (A) at the onset of SE has no effect, and seizure activity can continue for several hours. Treatment with 10 mg/kg s.c. diazepam at the onset of SE (B) rapidly blocks seizure activity, returning EEG amplitudes to normal values.